Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Income Statement [Abstract]        
Revenues $ 1,491 $ 839 $ 2,854 $ 1,687
Cost of Revenues 391 256 727 520
Gross Profit 1,100 583 2,127 1,167
Operating Expenses        
Research and development 796 253 1,752 523
Sales and marketing 681 479 1,314 811
General and administrative 3,018 3,530 6,368 6,473
Acquisition related costs 510 647 16
Amortization of intangibles 820 804 1,633 1,607
Total Operating Expenses 5,825 5,066 11,714 9,430
Loss from Operations (4,725) (4,483) (9,587) (8,263)
Other Income (Expense)        
Interest expense (509) (80) (865) (902)
Loss on exchange of debt for equity (160) (160)
Change in fair value of derivative liability 48
Gain on the sale of Sysorex Arabia 23
Other income/(expense) 163 (9) 232 (12)
Total Other Income (Expense) (506) (89) (793) (843)
Net Loss from Continuing Operations (5,231) (4,572) (10,380) (9,106)
Loss from Discontinued Operations, Net of Tax (1,283) (2,993)
Net Loss (5,231) (5,855) (10,380) (12,099)
Net Income Attributable to Non-controlling Interest 9 3 4 2
Net Loss Attributable to Stockholders of Inpixon (5,240) (5,858) (10,384) (12,101)
Deemed dividend to preferred stockholders (9,727) (11,235)
Deemed dividend for triggering of warrant down round feature     (1,250)
Net Loss Attributable to Common Stockholders $ (5,240) $ (15,585) $ (11,634) $ (23,336)
Net Loss Per Basic and Diluted Common Share        
Loss from continuing operations $ (0.56) $ (39.49) $ (1.69) $ (86.85)
Loss from discontinued operations (3.54) (12.78)
Net Loss Per Share - Basic and Diluted $ (0.57) $ (43.05) $ (1.69) $ (99.64)
Weighted Average Shares Outstanding        
Basic and Diluted 9,257,898 362,060 6,889,873 234,198